Senescence is a protective mechanism that induces permanent cell cycle arrest to prevent transmission of defects to the next generation, particularly to stop malignant transformation. Replicative senescence occurs after repeated cell division critically shortens telomeres, while induced senescence occurs after oncogene activation, mitochondrial deterioration, oxidative stress or DNA damage (Munoz-Espin & Serrano, 2014) . As ageing drives tumorigenesis and telomere shortening, it induces senescence via both pathways.
Most senescent cells develop altered secretory activities known as a senescence-associated secretory phenotype (SASP). The SASP releases proinflammatory cytokines (e.g., IL-1, IL-6) and chemokines (e.g., IL-8, GROα), growth factors (e.g., G-CSF, bFGF), and proteases (e.g., MMPs, PAI-1) (Coppe et al., 2008) , conferring diverse activities. Thus, although cell cycle arrest during senescence limits cancer and the SASP instructs clearance of preneoplastic cells (Kang et al., 2011) , this is balanced against establishment of a chronic inflammatory microenvironment that can damage tissue, drive disease and promote tumorigenesis if senescent cells persist (Grivennikov, Greten, & Karin, 2010) . IL-1α acts in an autocrine/paracrine fashion to drive the SASP (Gardner, Humphry, Bennett, & Clarke, 2015; Orjalo, Bhaumik, Gengler, Scott, & Campisi, 2009) , with upstream expression controlled in part by ATM/ATR liberation of GATA4 from p62-directed autophagy (Kang et al., 2015) and/or an mTORC1-dependent pathway (Laberge et al., 2015) . However, how IL-1α is cleaved, activated or released during senescence to enable it to drive the SASP is unknown.
Interleukin-1 (IL-1) is an ancient cytokine that exerts effect on both innate and adaptive immunities. IL-1α and IL-1β are the principal ligands that bind to the type 1 IL-1 receptor (IL-1R1), causing recruitment of the IL-1 receptor accessory protein (IL-1RAP) and subsequent interaction with the signalling adapter MyD88 (Dinarello, 2009) . A consequent phospho-signalling cascade activates NF-κB leading to multiple effects on immunity including cytokine secretion, upregulation of adhesion and/or MHC/costimulatory molecules, increased vascular permeability, TH17 cell differentiation, and effector T-cell proliferation in the presence of regulatory T cells (Sims & Smith, 2010) . These powerful actions of IL-1 are countered by a receptor antagonist (IL-1RA), a decoy receptor (IL-1R2), and production of IL-1α and IL-1β as pro-proteins that require cleavage for full biological activity. IL-1α is canonically cleaved by calpain, which occurs upon necrosis in some cell types and significantly increases activity (Burzynski, Humphry, Bennett, & Clarke, 2015; Zheng, Humphry, Maguire, Bennett, & Clarke, 2013) , while IL-1β is activated by caspase-1 (Black et al., 1988) after inflammasome engagement (Martinon, Burns, & Tschopp, 2002) . How IL-1α is released without necrosis is unknown and puzzling since IL-1α release is inhibited in
Casp1
−/− mice (Kuida et al., 1995; Li et al., 1995) , even though IL-1α is not a caspase-1 substrate. However, the original Casp1 −/− mice have an inactivating passenger mutation in Casp11 (Kayagaki et al., 2011) , suggesting caspase-11 might activate IL-1α. Murine caspase-11 and the human orthologues caspase-4 and caspase-5 are required for noncanonical inflammasome activation in response to intracellular LPS (icLPS) from bacterial infection (Kayagaki et al., 2011; Shi et al., 2014) , and control monocyte IL-1 release (Vigano et al., 2015) .
Direct binding of LPS to caspase-11, caspase-4 or caspase-5 leads to pyroptosis and/or NLRP3 inflammasome activation, with IL-1β and/ or IL-1α release (Kayagaki et al., 2011; Shi et al., 2014 We show that IL-1α is specifically cleaved and activated at a conserved site by caspase-5 and caspase-11, but not caspase-4.
Knockdown of caspase-5 or expression of a caspase site mutant reduces release of IL-1α after icLPS stimulation. IL-1α cleavage and release from murine macrophages after icLPS require only caspase-11, while IL-1β needs both caspase-11 and caspase-1. Importantly, we
show caspase-5 and caspase-11 are required for senescent cells to establish the IL-1α-dependent SASP. Thus, IL-1α is a direct substrate for inflammatory caspases during noncanonical inflammasome activation and senescence.
| RE SULTS

| Caspase-5 cleavage of human IL-1α at a conserved site increases activity
Although noncanonical inflammasomes that utilize caspase-4 and caspase-5 result in IL-1α and/or IL-1β release (Kayagaki et al., 2011; Shi et al., 2014) , their role in cleavage or secretion of IL-1α is unknown. Thus, we investigated whether IL-1α could be proteolytically activated by these caspases. Incubation of recombinant pro-IL-1α
with active inflammatory caspases revealed that caspase-5 cleaved IL-1α to a ~19 kDa fragment, while caspase-1 or caspase-4 did not Figure 1f ) and thus prevented activation ( Figure 1g ). This shows that caspase-5 increases IL-1α activity by direct processing at a conserved site located adjacent to the calpain site ( Figure 1h ).
| Release of cleaved IL-1α from human cells requires caspase-5
Due to the similar size of calpain-and caspase-5-cleaved IL-1α, we produced a peptide antibody that was reactive to the region between the calpain and caspase-5 sites (Supporting information Figure S1a) and developed an ELISA that recognized caspase-5-cleaved IL-1α, but not pro-IL-1α or calpain-cleaved IL-1α ( Figure 2a and Supporting information Figure S2b ). We also established an IL-1α ELISA that recognized total cleaved IL-1α, but not pro-IL-1α (Supporting information Figure S1c ). To test IL-1α processing and release in cells, we 
| Release of cleaved IL-1α from murine macrophages requires caspase-11
Caspase-11 is the murine orthologue of human caspase-4 and caspase-5, with all directly binding icLPS (Kayagaki et al., 2013; Shi et al., 2014) , signifying functional conservation. Although caspase-4 
is constitutively expressed (Kajiwara et al., 2014) , only caspase-5 
IL-1α as empty vector-transfected cells (Figure 3k ). Importantly, no difference in viability (Supporting information Figure S3a ,b) or IL-1β release after icLPS was seen between groups (Figure 3l ), indicating effect on IL-1α only. Together, these data show that caspase-11
cleavage of murine IL-1α at D 106 A is required for full activity and release from murine macrophages, while IL-1β activation and release still require caspase-1 and caspase-11.
| Caspase-5 is required for the IL-1α-dependent senescent-associated secretory phenotype
The SASP directs clearance of senescent cells, but also drives chronic inflammation that can promote disease and unhealthy ageing. As IL-1α drives the SASP, we investigated whether caspase-5 is required for IL-1α release during senescence. We utilized the well- Caspase-5 was also required for the SASP in WI-38 cells (Supporting information Figure S7a -e). With either cell type, CASP5 knockdown did not alter SAβG or proliferation levels (Supporting information Figure S8a ,b). The SASP is dependent on cGAS sensing of cytosolic chromatin, which drives interferon signalling (Gluck et al., 2017; Yang, Wang, Ren, Chen, & Chen, 2017) . As CASP5 is interferon responsive, we tested whether its expression was cGAS-dependent.
cGAS knockdown resulted in reduced release of IL-1α and IL-6, as 
| Caspase-11 is required for immune surveillance of senescent cells in vivo
To investigate whether caspase-11 is required for the SASP in vivo, we used a mouse liver model of NRAS-induced senescence.
Using hydrodynamic tail vein injection, we delivered Nras-
IRES-Casp11 shRNA or Nras-IRES-Control shRNA constructs
that undergo transposon-mediated stable integration into hepatocytes (Kang et al., 2011) . This system was chosen as it de- 
| D ISCUSS I ON
Due to the powerful, pleiotropic effects of IL-1, unprecedented levels of control and feedback pathways are required to mount an immune response that resolves an insult without causing overt tissue damage. For example, multiple inflammasomes have evolved to distinguish tissue damage, environmental pollutants, bacteria, viruses, fungi and protozoa. IL-1 also drives homeostatic processes such as thermoregulation (Dinarello, 2009) , regulatory B-cell differentiation (Rosser et al., 2014) , intestinal integrity (Jung et al., 2015) , and the immune surveillance and clearance of senescence cells (Kang et al., 2011) . However, how IL-1α is cleaved, activated and released was unknown.
We find that IL-1α is directly cleaved by caspase-5 and caspase-11 at a conserved site, leading to full cytokine activity. Expression of a caspase site mutant IL-1α or knockdown of CASP5 prevents release of cleaved IL-1α from cells, while IL-1α cleavage and release from murine macrophages require only caspase-11, with IL-1β needing both caspase-11 and caspase-1. Importantly, the IL-1α-dependent SASP requires caspase-5 and caspase-11 in vitro and in vivo. Thus, IL-1α
is a direct substrate of inflammatory caspases during noncanonical inflammasome activation and senescence.
The original Casp1 −/− mice (Kuida et al., 1995; Li et al., 1995) showed loss of IL-1β release from macrophages and during endotoxaemia. Unexpected reduced levels of IL-1α were also found, which has remained a puzzle as IL-1α is not a caspase-1 substrate. However, Casp1 −/− mice inherited a Casp11 inactivating passenger mutation from the 129/Sv background (Kayagaki et al., 2011 (Kayagaki et al., 2011) , supporting this concept. The primary role of caspase-4/5 and caspase-11 is thought to be LPS binding, and few substrates known. Gasdermin D is shown to be a key substrate for caspase-11, caspase-4/5 and indeed caspase-1 (Kayagaki et al., 2015; Shi et al., 2015) . We now report IL-1α as a direct substrate for caspase-5 and caspase-11.
F I G U R E 5
Although independent publications show cleavage of IL-1α greatly increases activity (Afonina et al., 2011; Zheng et al., 2013) , others contest this (Kim et al., 2013) . by HPLC, which typically denatures proteins due to the organic solvent mobile phase, and we find denatured and refolded pro-IL-1α has more activity than native pro-IL-1α (Zheng et al., 2013) .
Regardless, how IL-1α is released and if cleavage is required was unknown. Gasdermin D-mediated pore formation can allow IL-1α
to exit cells (Kayagaki et al., 2015; Shi et al., 2015) . However, because all tested IL-1α ELISA kits only recognize the cleaved form In addition, pro-IL-1α is bound to IL-1R2 inside many cells, which prevents activation by calpain (Burzynski et al., 2015; Zheng et al., 2013) . However, caspase-1 can cleave IL-1R2 to enable IL-1α activation, and this action may partly control canonical IL-1α release (Zheng et al., 2013) . Interestingly, caspase-5, but not caspase-4, also cleaves IL-1R2 (Zheng et al., 2013) . After canonical stimuli (e.g., LPS/ATP), IL-1α release is dependent on ASC and NLRP3 (Kayagaki et al., 2011) , while noncanonical stimuli only require caspase-11 for cleaved IL-1α release (Figure 3i and Kayagaki et al., 2011) . This suggests that canonical IL-1α release could proceed via NLRP3 caspase-1 activation and cleavage of IL-1R2, followed by calpain cleavage of IL-1α, while noncanonical pathways could lead to IL-1α release after direct cleavage of IL-1R2 and IL-1α by caspase-5/11.
In murine systems, caspase-11 binds LPS, increases caspase-1 cleavage of IL-1β (Wang et al., 1998) , activates gasdermin D (Kayagaki et al., 2015; Shi et al., 2015) and now also directly cleaves and activates IL-1α. In humans, an ancestral gene duplication resulted in CASP4 and CASP5, with caspase-4 suggested as the closer homologue of caspase-11 (Shi et al., 2014) . Both caspase-4 and caspase-5
bind LPS and target gasdermin D, but only caspase-5 can complement Casp11 −/− cells (Shi et al., 2014) , only CASP5 and Casp11 are upregulated in response to LPS (Figure 3a,b) , and only caspase-5/11
can cleave IL-1α, suggesting a closer functional connection. We suggest caspase-4 and caspase-5 have most likely undergone subfunctionalization, with functionality of the ancestral Casp11-like gene now distributed between both. However, if each performs nonredundant roles, and what these are, is still unknown.
Although IL-1α induces sterile inflammation upon release from damaged cells, it also drives the SASP, but in this context IL-1α release or surface presentation occurs without cell death ( Figure 4g and Gardner et al., 2015) . This excludes the usual notion that IL-1α is passively released (Kayagaki et al., 2011) . IL-1α expression during the SASP is controlled in part by ATM/ATR liberation of GATA4 from p62-directed autophagy (Kang et al., 2015) and/or an mTORC1-dependent pathway (Laberge et al., 2015) . Also, redox balance and Ca implying cleaved IL-1α release occurs separately from IL-1β (e.g., without caspase-1/NLRP3/ASC), in contrast to other studies (Acosta et al., 2013) . Indeed, IL-1β release after icLPS requires caspase-1 and caspase-11, while IL-1α only requires caspase-11 (Figure 3g-j) .
Together, this suggests that cleavage of IL-1α by caspase-5/11 during senescence leads to release of active IL-1α only, which drives the SASP. Interestingly, CASP5 mutations are associated with cancers (Offman et al., 2005) , while CASP1 and CASP4 mutations are not (Soung et al., 2008) , suggesting a caspase-5-specific protective role against tumorigenesis that is in keeping with SASP-driven senescence surveillance.
In conclusion, we show that IL-1α is a direct substrate of the noncanonical inflammatory caspase-5 and caspase-11, with cleavage increasing cytokine activity and release. Conservation of the cleavage site between species implies that activation of IL-1α by caspase-5 or caspase-11 is important. Indeed, cleavage of IL-1α by caspase-5 or caspase-11 is essential for the SASP. Thus, directly targeting caspase-5 may reduce inflammation and limit the deleterious effects of senescent cells that accumulate during disease and ageing.
| MATERIAL S AND ME THODS
All material from Sigma-Aldrich unless otherwise stated.
| Cell culture
HeLa cells (ECACC) and primary mouse fibroblasts were cultured in DMEM with penicillin, streptomycin, L-glutamine and 10% FCS and passaged at 80% confluency. IMR-90 and WI-38 cells (ATCC)
were cultured in phenol red-free DMEM supplemented with penicil- (Clontech), as previously described (Young et al., 2009) crystal violet staining as previously described (Gardner et al., 2015) .
| IL-1 Bioassays and inflammasome activation
HeLa cells or mouse fibroblasts were plated (10,000 cells/well,
48-well plate) and incubated (16 hr, 37°C). Media was refreshed
and cells incubated (6 hr, 37°C) ± cleavage assay products (1.5 µl).
Specific IL-1 activity was inferred by the effect of neutralizing antibodies (2 µg/ml; same as for Westerns), on IL-6 production. Every experiment contained a media only negative control and a recombinant IL-1 (10 ng/ml; PeproTech) positive control. For noncanonical, cells were primed with ultrapure LPS (1 µg/ml, 4 hr; InvivoGen) in full media, transfected with ultrapure LPS (5 µg/ml) using FuGENE HD (2.5 µl/ml; Promega) and incubated in Opti-MEM (37˚C, 18 hr).
For canonical, cells were primed with ultrapure LPS (1 µg/ml, 4 hr) in full media, treated with ATP (5 mM, pH7; InvivoGen) and incubated in Opti-MEM (37˚C, 18 hr).
| Recombinant protein expression, purification and cleavage
Pro-IL-1α/β or pro-caspase-5 cDNAs were cloned into pGEX-4T-3 (GE) or pcDNA3 (Invitrogen), with mutations introduced by sitedirected mutagenesis. For bacterial expression, IPTG-induced Rosetta cultures were lysed (PBS 1×; DTT 1 mM; EDTA 10 mM;
benzonase 30 U/ml; lysozyme 55 kU/g (both Novagen); protease inhibitor cocktail) with sonication, and clarified by centrifugation (5,525 g, 1 hr, 4°C). Filtered supernatants were loaded onto a GSTrap column (GE), washed (PBS; DTT 1 mM; EDTA 1 mM) and eluted (Tris 50 mM; NaCl 100 mM; DTT 1 mM; reduced l-glutathione 50 mM; adjusted to pH 8) using an ÅKTA FPLC system (GE). Eluted protein was dialysed overnight (Tris 10 mM, pH8; NaCl 50 mM) and stored in glycerol (10%) at −80°C. IL-1 protein concentration was normalized by SDS-PAGE, Coomassie staining (G-250; Bio-Rad) and quantitative imaging (Odyssey, Li-Cor).
Recombinant IL-1 (4 µg/ml) was incubated (1 hr, 37°C) with active caspase (100 U or 10 U; all Enzo) in reaction buffer (human-HEPES 50 mM, pH 7.4; NaCl 100 mM; CHAPS 0.1%; EDTA 1 mM; glycerol 10%; DTT 10 mM) (mouse-MES 100 mM, pH 6.5; CHAPS 0.1%; PEG 10%; DTT 10 mM). Where indicated, LEVD-FMK (330 µM; Enzo) was added. Recombinant IL-1 (4 µg/ml) was incubated (1 hr, RT) with active calpain (100 U; Calbiochem) in reaction buffer (NaCl 100 mM; CaCl2 2 mM; DTT 1 mM).
| Induction of mouse hepatocyte senescence in vivo
Mice were handled and kept under pathogen-free conditions in accordance with UK law and institutional guidelines at the University of Cambridge and CRUK Cambridge Institute. Transposon-mediated gene transfer by hydrodynamic tail vein injection was as previously described (Dauch et al., 2016; Kang et al., 2011) . Briefly, short-hairpin oligomers targeting Casp11 (5'-TACCATCTATCAGATATTCAA-3')
were cloned into MSCV-miR30-puro before subcloning into pCaNIG-miR30 (from Lars Zender (Dauch et al., 2016) ). Vectors were prepared using the EndoFree MaxiPrep Kit (Qiagen). Female C57BL/6 mice (Charles River) were injected via the lateral tail vein with pCaNIG-miR30 (20 µg) and SB13 transposase vector (5 µg) in PBS at a volume equivalent to 10% of body weight in <10 s, and livers harvested at the times indicated.
| Western blotting and cytokine detection
Western blotting was performed as previously described. Blocked cleavage site in IL-1α was generated by immunizing rabbits with a KLH-conjugated peptide, followed by affinity purification and biotinylation (Innovagen). This was then used as the detection reagent in a standard sandwich ELISA using a goat anti-human IL-1α antibody (R&D) as capture.
| Gene expression analysis
RNA was isolated (RNeasy, Qiagen) and converted to cDNA using AMV reverse transcriptase (Promega). qPCR used TaqMan probes with AmpliTaq Gold (Life Technologies) in a Rotor-Gene thermocycler (Corbett). Gene expression was evaluated using the 2 −ΔΔCT method using GUSB as a reference gene. qPCR data are displayed as
, but statistical analysis was performed on the untransformed ΔΔCT values. RNA-Seq data were from GEO GSE72404.
| Assessment of Cell Surface IL-1α
Cells were detached (Accutase), fixed (2% formaldehyde; 5 min, RT), 
| Immunofluorescence and Immunohistochemistry
After processing, paraffin sections were cleared before antigen retrieval with sodium citrate (10 mM; pH 6), blocking with M.O.M. 
| Statistical Analysis
All statistical analyses were carried out using Prism 7 (GraphPad).
Data were analysed by unpaired t test (two-tailed), one-way ANOVA with Dunnett's post hoc or one-way ANOVA with Tukey's post hoc. n = individual biological replicate performed in duplicate. The in vitro experiments typically required sample sizes of n = 3-4 to provide adequate power, and produced data that were normally distributed. 
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